OPTIMIZING ELIMINATION OF ANTI-CARDIOLIPIN ANTIBODIES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AS A COMPONENT OF PATHOGENETIC THERAPY FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：0
|
作者：
Emelyanova, O. [1 ]
Rusanova, O. [1 ]
Trofimenko, A. [1 ]
机构：
[1] Res Inst Clin & Expt Rheumatol, Volgograd, Russia
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2024年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P1017
引用
收藏
页码：S474 / S474
页数：1
相关论文
共 50 条
  • [31] Antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus
    Formiga, F
    Moga, I
    Canet, R
    Pac, M
    Mitjavila, F
    Pujol, R
    REVISTA CLINICA ESPANOLA, 1996, 196 (11): : 734 - 736
  • [32] Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients
    Formiga, F
    Mitjavila, F
    Pac, M
    Moga, I
    LUPUS, 1997, 6 (05) : 486 - 486
  • [33] The chronological change of anti-cardiolipin and anti-β2-GPI antibodies in patients with antiphospholipid syndrome.
    Mengoni, A
    Katsumata, K
    Whiston, C
    Fofi, C
    Khamashta, MA
    Hughes, GRV
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S368 - S368
  • [34] Antiphosphatidylethanolamine antibodies contribute to the diagnosis of antiphospholipid syndrome in patients with systemic lupus erythematosus
    Balada, E
    Ordi-Ros, J
    Paredes, F
    Villarreal, J
    Mauri, M
    Vilardell-Tarrés, M
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2001, 30 (04) : 235 - 241
  • [35] REMOVAL OF PATHOGENIC ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WITH ANTIPHOSPHOLIPID SYNDROME
    Gontar, I. P.
    Ernelyanova, O.
    Maslakova, L. A.
    Paramonova, O. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 948 - 948
  • [36] Oxidatively modified lipoproteins and their antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus
    Roch, B
    Kopprasch, S
    Pietzsch, J
    Schröder, HE
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2004, 63 (04): : 331 - 337
  • [37] Detection of anti-Annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus
    Satoh, A
    Suzuki, K
    Takayama, E
    Kojima, K
    Hidaka, T
    Kawakami, M
    Matsumoto, I
    Ohsuzu, F
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (08) : 1715 - 1720
  • [38] ANTI-FACTOR XA ANTIBODIES ARE SIGNIFICANTLY INCREASED IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME
    Esen, Bahar Artim
    Pericleous, Charis
    MacKie, Ian
    Ioannou, Yiannis
    Rahman, Anisur
    Isenberg, David A.
    Giles, Ian
    RHEUMATOLOGY, 2013, 52 : 133 - 134
  • [39] "EXTRA"- CRITERIA ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS (PRELIMINARY DATA)
    Cheldieva, F.
    Reshetnyak, T.
    Cherkasova, M.
    Seredavkina, N.
    Lila, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 605 - 606
  • [40] ANTI-Factor Xa Antibodies ARE Significantly Increased in Patients with Systemic LUPUS Erythematosus and Antiphospholipid Syndrome
    Artim-Esen, Bahar
    Pericleous, Charis
    Mackie, Ian
    Ioannou, Yiannis
    Rahman, Anisur
    Isenberg, David A.
    Giles, Ian
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S739 - S739
12345